scholarly journals Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction

2017 ◽  
Vol 20 (4) ◽  
pp. 715-722 ◽  
Author(s):  
Emil Wolsk ◽  
David Kaye ◽  
Barry A. Borlaug ◽  
Daniel Burkhoff ◽  
Dalane W. Kitzman ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Preserved Ejection Fraction ◽  
Walk Test ◽  
Six Minute Walk Test ◽  
Patients With Heart Failure ◽  
Minute Walk

Chronotropic Incompetence Predicts Distance Walked in Six-Minute Walk Test in Heart Failure With Preserved Ejection Fraction

2020 ◽  
Vol 26 (11) ◽  
pp. 1024-1025
Author(s):  
Patricia Palau ◽  
Eloy Domínguez ◽  
Julia Seller ◽  
Clara Sastre ◽  
Antoni Bayés-Genís ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Preserved Ejection Fraction ◽  
Walk Test ◽  
Chronotropic Incompetence ◽  
Six Minute Walk Test ◽  
Minute Walk

scholarly journals Comparative efficacy of enalapril and valsartan in heart failure with mid-range ejection fraction

2021 ◽  
Vol 102 (5) ◽  
pp. 614-620
Author(s):  
T. A. Glebova ◽  
P. Yu Galin
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Brain Natriuretic Peptide ◽  
Natriuretic Peptide ◽  
Walk Test ◽  
Six Minute Walk Test ◽  
Natriuretic Peptide Level ◽  
Patients With Heart Failure ◽  
Peptide Level ◽  
Minute Walk

Aim. To compare the effectiveness of the angiotensin-converting enzyme inhibitor enalapril and the angiotensin II receptor antagonist valsartan in patients with heart failure with mid-range ejection fraction (HFmrEF) from the standpoint of the effect on the clinical picture, echocardiographic parameters and the level of the N-terminal fragment of the prohormone brain-type sodium (NT-proBNP). Methods. 110 patients with heart failure with mid-range ejection fraction were included in the study based on the City Clinical Hospital named after N.I. Pirogov of Orenburg between 2018 and 2020. All patients were divided into two randomized groups. Patients of the first group (n=55) were prescribed enalapril, the second group (n=55) valsartan. Each patient was followed up for 1 year. The six-minute walk test, NT-pro-brain natriuretic peptide level, echocardiography parameters were assessed in dynamics. Statistical analysis was performed by using Statistica 10.0 software, ShapiroWilk, MannWhitney, Wilcoxon tests. Results. During the year of observation in both groups, there was a significant decrease in the functional class of chronic heart failure (p 0.005) without a statistical difference between the groups (p=0.251). The distance during the six-minute walk test increased from 350 (310400) m to 490 (420530) m (p 0.001) in the first group, from 360 (330400) m to 510 (450520) m (p 0.001) in the second group, also without significant differences (p=0.361). The NT-pro-brain natriuretic peptide level decreased from 491 (410610) pg/ml to 286 (187350) pg/ml (p 0.001) in the first group, and from 446 (376534) pg/ml to 210 (143343) pg/ml (p 0.001) in the second, with a more significant change in the second group (p=0.020). The dynamics of echocardiography parameters were comparable in the groups (p 0.05), while ejection fraction normalized in 89.1% of patients received enalapril and 92.7% of patients received valsartan. Conclusion. The efficacy of enalapril and valsartan in heart failure with mid-range ejection fraction is comparable in its effect on the clinical picture and echocardiography parameters with a more pronounced decrease in NT-pro-brain natriuretic peptide when taking valsartan during a year of follow up.

scholarly journals Diagnostic, prognostic and therapeutic potential of 6-minute walk test in patients with heart failure

2020 ◽  
Vol 19 (6) ◽  
pp. 2460
Author(s):  
A. V. Budnevsky ◽  
A. Ya. Kravchenko ◽  
R. E. Tokmachev ◽  
T. A. Chernik ◽  
E. V. Tokmachev ◽  
...  
Keyword(s):  
Heart Failure ◽  
Therapeutic Potential ◽  
Effective Control ◽  
Walk Test ◽  
Six Minute Walk Test ◽  
Patients With Heart Failure ◽  
Appropriate Therapy ◽  
Heart Disorders ◽  
6 Minute Walk Test ◽  
Minute Walk

The six-minute walk test (6MWT) is a well-known exercise test used in medical practice to assess the functional status of patients with various chronic cardiovascular and respiratory diseases. The results of modern research describe new potential of 6MWT, which allow a more accurate interpretation and predict the course of diseases. Heart failure (HF) is the outcome of many structural and functional heart disorders. To improve the prognosis of patients with HF, early diagnosis, appropriate therapy and effective control of the disease course are important components. This review describes the diagnostic, prognostic and therapeutic potential of 6MWT in patients with HF.

Prognostic Significance and Determinants of the 6-Min Walk Test in Patients With Heart Failure and Preserved Ejection Fraction

2015 ◽  
Vol 3 (6) ◽  
pp. 459-466 ◽  
Author(s):  
Caroline Zotter-Tufaro ◽  
Julia Mascherbauer ◽  
Franz Duca ◽  
Benedikt Koell ◽  
Stefan Aschauer ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Prognostic Significance ◽  
Preserved Ejection Fraction ◽  
Walk Test ◽  
Patients With Heart Failure

scholarly journals Heart Rate Recovery in the First Minute at the Six-Minute Walk Test in Patients with Heart Failure

2014 ◽  
Author(s):  
Sabrina Lindemberg ◽  
Sergio Chermont ◽  
Mônica Quintão ◽  
Milena Derossi ◽  
Sergio Guilhon ◽  
...  
Keyword(s):  
Heart Failure ◽  
Heart Rate ◽  
Heart Rate Recovery ◽  
Walk Test ◽  
Six Minute Walk Test ◽  
Patients With Heart Failure ◽  
Minute Walk
Sign in / Sign up

Export Citation Format

Share Document